This can activate TLR2 signaling in tumor cells, leading to the development of a chemotherapy-resistant phenotype [31], and it has previously been shown that TLR2 and HMGB1 have an important role in the self-renewal of breast CSCs [32]. This evidence concerns the gene HMGB1 and neoplasm.